Creo Medical (GB:CREO) has released an update.
Creo Medical Group has announced that directors Kevin Crofton and Richard Rees have purchased additional shares following recent fundraising efforts, with transactions carried out at 24 pence per share. This move highlights the leadership’s confidence in the company’s growth prospects, potentially attracting the attention of investors in the stock market.
For further insights into GB:CREO stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
